The Globe and Mail reports in its Friday, May 1, edition that Stifel analyst Ian Gillies continues to rate Atkinsrealis Group, Stantec and WSP Global "buy." The Globe's David Leeder writes in the Eye On Equities column that Mr. Gillies gave his Atkinsrealis share target a $9 trim to $101. He lowered Stantec's share target to $140 from $160. Mr. Gillies gave his WSP Global share target a $40 cut to $280. Analysts on average target Atkinsrealis, Stantec and WSP Global shares at $118.57, $163.38 and $314.38. Mr. Gillies says in a note: "One of the key takeaways from my recent analyst marketing is how sour the mood is on Atkinsrealis/Stantec/WSP Global. This is a drastic change from the prior five-years where these stocks were top of mind to most investors given the robust growth outlooks and continuously improving estimates' outlook. Fundamentally, we believe mid-to-high teens EPS growth outlooks is a good base case over the next three to five years. Valuation remains the primary issue due to ongoing, elevated concerns regarding terminal value risk due to AI. In our view, valuations have upside to 20-21 times 2027E P/E, but are unlikely to reach prior highs unless clarity emerges on how AI will impact these businesses."